Since this FDA workshop in March a new paper by @jbercu Joel Bercu on LTL and NDEA has been published. It can be found here:
ANVISA now considers LTL limits for nitrosamines acceptable based upon this paper.
Other regulators are looking again at this issue. @kenyom01 @David @fernandaw